A bonus share is a free additional share given to existing shareholders from a company’s accumulated profits, offering a reward without any cash payment. A stock split divides each existing share into multiple lower-value shares, increasing the total number of shares...
The stock climbed sharply after approval of a bonus issue and stock split, improving affordability and liquidity. Despite this positive trigger, recent quarterly performance remains weak, guidance has been lowered, and capex plans deferred due to muted demand and...
SYNOPSIS: Nectar Lifescience approved an Rs. 81 crore share buyback at Rs. 27 per share, amounting to 3 crore shares via the tender route, excluding promoters, with 24th December 2025 set as the record date. During Wednesday’s trading session, shares of a company...
Synopsis: Gujarat Natural Resources Limited will meet on 12th December 2025 to consider splitting its ₹10 equity shares to enhance liquidity and make the shares more affordable. This Small-cap stock, engaged in upstream oil and gas exploration and production through...
SYNOPSIS: Paramatrix Technologies will acquire 100 percent of Metasys Software for Rs. 14.1 crore, strengthening its global IT service capabilities, expanding its client base, and enhancing revenue through added technical expertise and recurring business. During...
Synopsis: The shares of this construction company skyrocketed 14% following the announcement made by the company about the rights issue at an almost 54.5% discount. The shares of this company, which is involved in engineering and construction of infrastructure...
SYNOPSIS: Board of Authum Investment & Infrastructure approved a 4:1 bonus issue, increasing paid-up capital to 84.92 crore shares, and raised authorised share capital to Rs. 128 crore, with bonus shares issued from available reserves. During Monday’s trading...
A bonus share is a free additional share given to existing shareholders from a company’s accumulated profits, offering a reward without any cash payment. A stock split divides each existing share into multiple lower-value shares, increasing the total number of shares...
Synopsis: The shares of this micro-cap healthcare company are in focus today after the management in its announcement stated the board has approved of the buyback worth about Rs 19.14 crore. The company, which is a digitally first consumer healthcare company with a...
Synopsis: Nectar Lifesciences jumped sharply after the company announced that it would have a Board meeting on December 3, 2025, to consider a share buyback proposal. The shares of this leading pharma company engaged in manufacturing APIs and...
